ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
120.434 IP-LS
Project title
Preclinical in vivo proof of mechanism study of selective mTORC1 inhibitors

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Maier Timm
Universität Basel

Scientific management
Universität Basel

Implementation Partner


Aukera Therapeutics GmbH
www.uid.admin.ch/Detail.aspx?uid_id=CHE277689271